The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...